Liron Israel, PhD, earned her MS degree in medicinal chemistry from the Hebrew University, Jerusalem, and her PhD from Bar-Ilan University, Ramat-Gan, Israel. During that time, her research focused on radiochemistry and PET radiotracers (including manufacturing and QC for patients), multistep organic synthesis and nanotechnology aimed at biomedical applications such as siRNA delivery and MRI. Dr. Israel has also worked in industrial R&D in the fields of process development and multistep organic synthesis of active pharmaceutical ingredients (APIs) in GMP/GLP surroundings. She completed her postdoctoral training at Cedars-Sinai in the Department of Neurosurgery in 2019, where her research focused on nanocarriers with blood-brain barrier (BBB) crossing abilities for imaging and treatment of brain tumors and Alzheimer’s disease. She is currently a project scientist working on nano drug delivery systems, cancer vaccines, and immunotherapy aimed to treat tumors of the brain.